Both a Danish and an English version of the Investor Portal is available.
To log-on to the Investor Portal use your VP-reference or NEM-ID:
Access Novo Nordisk Investor Portal (UK)
The Investor Portal is administered by VP Securities A/S. VP Securities A/S is a Central Securities Depository (CSD) in Denmark authorised by the Danish Financial Supervisory Authority (Finanstilsynet) according to the Danish Securities Trading Act. Learn how VP Securities A/S process personal data .
For further information, please refer to our
Notice of Personal Data
This also applies to notices to convene general meetings which are no longer sent to shareholders as hardcopy by regular mail.
Shareholders are encouraged to sign up and register their email address via Novo Nordisk A/S’ InvestorPortal
Shareholders who wish to receive company information are responsible for ensuring that Novo Nordisk A/S is in possession of the correct email address and should sign up via the InvestorPortal . Learn more about how to sign-up your email .
Receipt of electronic communication from Novo Nordisk requires access to an email and a pdf-viewer.
Announcements of a general nature will be made available at novonordisk.com.
Holders of such certificates were thus encouraged to contact Danske
Bank, Corporate Actions, via contact details below
no later than 4
in order to have their shareholdings registered
and the physical certificates converted into registered shares in Novo
Nordisk A/S and Novozymes A/S.
If the conversion was not completed by 4 November 2018, the corresponding shares have been sold pursuant to the Danish Companies Act. Holders of physical share certificates and interim certificates will be entitled to collect the net proceeds of the share sale within a period of three years following the sale.
See the announcement as published on Virk.dk for further information (in Danish) .
The above applies to holders of physical share certificates and interim certificates in former Nordisk Gentofte A/S and Novo Industri A/S only and does not affect shareholders of registered shares in Novo Nordisk A/S.
Danske Bank, 3886 Corporate Actions,
Holmens Kanal 2-12, 1092 København K,
Telephone: (+45) 45 14 36 94
To change your email address, please log on to the investor portal.
In our InvestorPortal guideline (pdf) you can learn how to add or update your email address.